Form Type: 4

SEC EDGAR Link
Accession Number:0001213900-22-019771
Date:2022-04-13
Issuer: ENZO BIOCHEM INC (ENZ)
Original Submission Date:

Reporting Person:

ERFANIAN HAMID
C/O ENZO BIOCHEM, INC.
527 MADISON AVENUE NEW YORK, NY 10022

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK, $0.01 PAR VALUE 2022-04-13 A 10,000 a $2.90 270,000 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (TO ACQUIRE COMMON STOCK) 3.39 2021-11-08 deemed execution date A 700,000 (a) 2022-11-08 2026-11-08 common stock 700,000 $3.39 700,000 direct
Footnotes
IDfootnote
f1 the reporting person was granted 700,000 stock options. the stock options have a five-year term and will vest, subject to the individual's continued employment with enzo biochem, inc., in three equal annual installments, beginning on november 8, 2022.
WhaleWisdom Logo

Elevate your investments